S&P 500 Retreats From Record High as AI Stocks Slide, Retail Sales Disappoint 
European Stocks Edge Higher as Fed Rate Pause Bets Rise 
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Trump Administration Releases New UFO Files and Apollo Mission Records 
The pandemic is still disrupting young people’s careers 
Oil Prices Rise as U.S.-Iran Tensions Grip Strait of Hormuz 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Canada Faces 50% U.S. Tariffs as Trade Tensions Threaten USMCA Talks 
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight 
Colombia Earthquake Losses Estimated at $9.58 Billion as Reconstruction Challenge Mounts 
Citadel Warns High Treasury Yields Pose Broader Market Risks 
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
Malaysia Inflation Eases to 1.8% in July, Below Forecast 
Add as a preferred source on Google
South Korean researchers have developed a Korean-style Mediterranean diet that helps prevent cardiovascular disease by reducing the proportion of carbohydrates while increasing the ratio of fat and protein.
The diet consisted of carbohydrates, fat, and protein in a 5:3:2 ratio.
The Gangnam Severance Hospital team offered the diet to 92 hyperlipidemia patients for 10 weeks and tracked their observations.
Patients who followed the Korean-style Mediterranean diet cut their average weight by 1.76 kilograms and trimmed their waist size by 1.73 centimeters.
In contrast, those from the general diet group only marked a 0.26-kilogram decline in average weight and 0.15 centimeters in waist size.
Those that took the Mediterranean diet also exhibited a meaningful reduction in dyslipidemia indices, including total cholesterol, low-density lipoprotein (LDL) cholesterol in the blood, and steatosis index.
They also showed declines in other body inflammation indices, such as fasting blood sugar, leukocyte value, and insulin-resistant index.
